Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Journal of Taibah University Medical Sciences|August 19, 2022
Lepromatous leprosy with a suspected 30-year incubation period: A case report of a practically eradicated areaNiporn Jariyakulwong, Narachai Julanon, Charupong Saengboonmee
Anticancer Research|December 1, 2021
Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising DrugCharupong Saengboonmee, Thanachai Sanlung, Sopit Wongkham
International Immunopharmacology|June 26, 2023
Metformin as a booster of cancer immunotherapyJutatip Panaampon, Yubin Zhou, Charupong Saengboonmee
Journal of Hepato-Biliary-Pancreatic Sciences|May 30, 2021
Obesity and cholangiocarcinoma: A review of epidemiological and molecular associationsSoravis Osataphan, Treerat Mahankasuwan, Charupong Saengboonmee
World Journal of Gastroenterology|October 1, 2024
Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinomaRonnakrit Trakoonsenathong, Ching-Feng Chiu, Charupong Saengboonmee
Scientific Reports|January 9, 2016
High glucose enhances progression of cholangiocarcinoma cells via STAT3 activationCharupong Saengboonmee, Wunchana Seubwai, Chawalit Pairojkul, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 26, 2021
High glucose: an emerging association between diabetes mellitus and cancer progressionSuangson Supabphol, Wunchana Seubwai, Sopit Wongkham, et al.
Expert Review of Anticancer Therapy|April 13, 2023
Revision of potential prognostic markers of cholangiocarcinoma for clinical practiceCharupong Saengboonmee, Sumalee Obchoei, Kanlayanee Sawanyawisuth, et al.
In Vivo (Athens, Greece)|June 23, 2022
Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal TractFuchun Zeng, Yubin Zhou, Theerawat Khowtanapanich, et al.
Expert Review of Anticancer Therapy|April 21, 2018
Prognostic biomarkers for cholangiocarcinoma and their clinical implicationsCharupong Saengboonmee, Kanlayanee Sawanyawisuth, Yaovalux Chamgramol, et al.
Pageof 6